Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Assets (2023 - 2025)

Historic Assets for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $601.6 million.

  • Nuvation Bio's Assets rose 524.55% to $601.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $601.6 million, marking a year-over-year increase of 524.55%. This contributed to the annual value of $540.6 million for FY2024, which is 1301.05% down from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's Assets is $601.6 million, which was up 524.55% from $647.2 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Assets ranged from a high of $657.1 million in Q1 2023 and a low of $492.5 million during Q1 2025
  • Its 3-year average for Assets is $601.1 million, with a median of $613.1 million in 2024.
  • Data for Nuvation Bio's Assets shows a peak YoY increase of 881.46% (in 2025) and a maximum YoY decrease of 1967.56% (in 2025) over the last 5 years.
  • Nuvation Bio's Assets (Quarter) stood at $621.5 million in 2023, then dropped by 13.01% to $540.6 million in 2024, then grew by 11.27% to $601.6 million in 2025.
  • Its Assets was $601.6 million in Q3 2025, compared to $647.2 million in Q2 2025 and $492.5 million in Q1 2025.